People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Immune Design Corp. | — | Biotechnology | Series C | $144.6M | $2.0B | 2010 |
| Turnstone Biologics Corp. | — | Biotechnology | Series C | $122.1M | $2.2B | 2019 |
Sammy Farah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sammy Farah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jerel Davis | 1 | 13 |
| Rishi Gupta | 1 | 12 |
| Richard Klausner | 1 | 7 |
| Brian Atwood | 1 | 6 |
| Stefan Larson | 1 | 4 |
| James Paul Rickey | 1 | 3 |
| Alain Schreiber | 1 | 3 |
| Patrick Machado | 1 | 3 |
| Robert Gould | 1 | 3 |
| Steven Reed | 1 | 2 |
| David Baltimore | 1 | 2 |
| Bruce Carter | 1 | 2 |
| Peter V. Svennilson | 1 | 2 |
| Jane Henderson | 1 | 2 |
| Stephen R. Brady | 1 | 2 |
| Edward Penhoet | 1 | 2 |
| Brad Bolzon | 1 | 2 |
| David Paul Parker | 1 | 1 |
| Edward V. Penhoet | 1 | 1 |
| Steve Reed | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.